Literature DB >> 19519690

Examination of outcome following abdominoperineal resection for adenocarcinoma in Oxford.

W Chambers1, A Khan, R Waters, I Lindsey, B George, N Mortensen, C Cunningham.   

Abstract

AIM: Abdominoperineal resection (APR) has been shown to have poor outcomes compared with anterior resection (AR) in the treatment of rectal cancer. We compared APR outcomes with those for low AR.
METHOD: Lower third rectal cancers treated at the John Radcliffe Hospital with APR and low AR were examined using a prospectively collected database augmented with review of patient records. For all cases (APR and low AR), a range of patient, cancer and outcome data were collected. A selected group was created on the basis of exclusions. Outcomes for the global and selected APR and low AR groups were compared using the Kaplan-Meier method. CRM+ve and CRM-ve APR cases were compared.
RESULTS: Between 1994 and 2003, 70 APR and 93 low AR were performed. After exclusions, 42 APR and 81 low AR remained. Median follow-up was 4.8 years. Five year survival for the APR group was significantly worse than for the low AR group. The APR group showed significantly fewer T0 cancers and significantly more T3 cancers. CRM R1 involvement was significantly higher for the APR group. The CRM+ve APR group contained significantly more later stage cancers, more defective resection specimens, more abscesses and fistulas and was associated with more local recurrence.
CONCLUSIONS: These data showed that APR led to worse results than low AR in terms of overall survival and circumferential margin involvement, but that the cancers treated with APR tended to be more locally advanced.
© 2010 The Authors. Colorectal Disease © 2010 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 19519690     DOI: 10.1111/j.1463-1318.2009.01939.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

1.  Therapeutic results of abdominoperineal resection in the prone jackknife position for T3-4 low rectal cancers.

Authors:  Xiang Hu; Liang Cao; Jian Zhang; Pin Liang; Ge Liu
Journal:  J Gastrointest Surg       Date:  2014-11-04       Impact factor: 3.452

Review 2.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

3.  The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer.

Authors:  Muhammad Amir Saeed Khan; Chin W Ang; Abdul Rahman Hakeem; Nigel Scott; Rick Nigel Saunders; Ian Botterill
Journal:  J Gastrointest Surg       Date:  2017-09-18       Impact factor: 3.452

4.  The significance of extramural venous invasion in R1 positive rectal cancer.

Authors:  N M Ormsby; H N Bermingham; H M Joshi; M Chadwick; A Samad; D Maitra; M Scott; S Kelly; K Whitmarsh; R Rajaganeshan
Journal:  Int J Colorectal Dis       Date:  2016-10-01       Impact factor: 2.571

5.  Update and debate issues in surgical treatment of middle and low rectal cancer.

Authors:  Nam Kyu Kim; Min Sung Kim; Sami F Al-Asari
Journal:  J Korean Soc Coloproctol       Date:  2012-10-31

6.  Better operative outcomes achieved with the prone jackknife vs. lithotomy position during abdominoperineal resection in patients with low rectal cancer.

Authors:  Peng Liu; Haidong Bao; Xianbin Zhang; Jian Zhang; Li Ma; Yulin Wang; Chunyan Li; Zhongyu Wang; Peng Gong
Journal:  World J Surg Oncol       Date:  2015-02-12       Impact factor: 2.754

Review 7.  Meta-analysis of oncological outcome after abdominoperineal resection or low anterior resection for lower rectal cancer.

Authors:  Xiao-Tong Wang; De-Gang Li; Lei Li; Fan-Biao Kong; Li-Ming Pang; Wei Mai
Journal:  Pathol Oncol Res       Date:  2014-11-28       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.